May 26, 2005: Orphagen is awarded a Small Business Investigative Research (SBIR) Phase I grant for drug discovery in the area of metabolic disease pdf version html version

September 23, 2005: National Institutes of Health awards Orphagen $460,339 to investigate novel treatments for sleep disorders pdf version html version